Gregg W. Stone: Short-Term DOACs Show Advantage Over DAPT Post-LAAO
Gregg W. Stone, Interventional Cardiologist, Director of Academic Affairs for Mount Sinai Heart Health System, Professor of Medicine at Icahn School of Medicine, shared a post on X about a recent article he and his colleagues co-authored, published in EHJ, adding:
“Now published in EHJ:
In 3 RCTs (n=704), 2-3-mo Rx w/DOACs (low dose in 2 trials) low device-related thrombosis (DRT) and major bleeding c/w DAPT, with NS Δ in death and stroke/SE.
DRT has been associated with thromboembolic events, and the RR of 0.61 for stroke/SE favors DOAC use.”
Title: Direct oral anticoagulants vs dual antiplatelet therapy after left atrial appendage occlusion: a meta-analysis of trials
Authors: Ahmed Samy Badran, Gregg W. Stone
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period
-
Oct 17, 2026, 16:24W. Alberto Sifuentes Giraldo: Exploring Peripheral Macrovascular Thrombosis in CAPS
-
Oct 17, 2026, 16:17Rishabh Jain: Could Rusfertide Transform Polycythemia Vera Management?
-
Oct 17, 2026, 16:16Fabrice Cognasse: Advancing Transfusion Medicine Through International Collaboration